Table 1.
SN | Antigen Conjugated with AuNP | GNP/Adjuvant | Immunization Mechanism | Immune Response | Ref. |
---|---|---|---|---|---|
1 | Surface antigens spike glycoprotein of avian coronavirus | Virus-like particles (VLP) by incubating the antigen with 100 nm AuNPs | Dose: Single, 10 μg Mode: Intramuscularly Animals: BALB/C mice and specific pathogen-free chickens |
|
[109] |
2 | Surface antigens gastroenteritis virus | Conjugated with 15 nm AuNPs | Guinea pigs twice subcutaneously with 125 μg, mice once intraperitoneally with 70 μg, and rabbits three times subcutaneously with 220 μg |
|
[84,110] |
3 | Glycoprotein antigen of respiratory syncytial virus | Nanorods | Human cell treatment in vitro | Human dendritic cells induced an immune activation (proliferation and expansion) of primary T cells. | [111] |
4 | Glycoprotein isolated from fixed rabies virus, strain Moscow 3253 | Conjugated with 15 nm AuNPs | Animal: Mice Mode: Intraperitoneally Dose: 25 μg in four booster doses, 50 μg was used |
Develop highly specific neutralizing antibodies against the virus. | [112] |
5 | Surface glycoprotein (gB) of human cytomegalovirus (CMV, a herpes virus) | Conjugated with AuNP | In vitro |
|
[113] |
6 | West Nile fever virus | Multiple sizes and shapes of AuNPs used: 20 and 40 nm nanospheres, 40 × 20 nm nanorods, and 40 × 40 × 40 nm nanocubes |
Animal: Mice Mode: Intraperitoneally Dose: 100 μg No. of doses: 2 |
|
[72] |
7 | Capsid (Cap) protein from pathogenic porcine circovirus | Conjugated with 23 nm GNPs | In vitro and mice immunized twice subcutaneously |
|
[114] |